“cancer” Archives

in
Entry Author Date Location
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer 03/10/17 San Diego
Biotech With Drug Developed by San Antonio Researcher Explores Sale 03/09/17 Texas
DePinho Announces His Departure from Houston’s MD Anderson 03/08/17 Texas
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
CureMatch Uses Analytics to Rank Best Options for Cancer Treatment 03/07/17 San Diego
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
​Ex-Vice President Biden to Speak About Cancer Moonshot at SXSW 03/06/17 Texas
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Human Impact of Innovation Super Saver Special Ends Today! 03/02/17 San Diego
Evestra Signs Deal with Glemark for Generic Version of NuvaRing 03/01/17 Texas
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Join Xconomy in June for ‘What’s Hot In Cancer Immunotherapy 2017’ 03/01/17 Seattle
With Eye On FDA, Kite Says CAR-T For Lymphoma Holds Up After 6 Months 02/28/17 National
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy 02/27/17 New York
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
UT’s Lynda Chin Responds to Flap Over MD Anderson and Watson Project 02/23/17 Texas
Argos Shares Crater on Futility Finding for Kidney Cancer Therapy 02/22/17 Raleigh Durham
Genomenon’s Software Seeks to Give Geneticists Faster Insights 02/21/17 Detroit Ann Arbor
Join Us: Xconomy Forum on Innovations with Widespread Human Impact 02/16/17 San Diego
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
Tarveda Nabs $30M More as Versant Helps Fund Cancer Drug Push 02/02/17 Boston
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
Polish Subsidiary of San Antonio Firm Gets $4.6M for Endometriosis 01/26/17 Texas
Purdue’s On Target Laboratories Lights Up the Fight Against Cancer 01/25/17 Indiana
Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy 01/24/17 Boston
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA 01/12/17 Boston
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio 01/09/17 Boston
Page 3 of 67 « previous page · next page »